Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (QoQ) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.14% |
| Dec 31, 2025 | 43.76% |
| Sep 30, 2025 | -2,953.31% |
| Jun 30, 2025 | 98.23% |
| Mar 31, 2025 | -14.81% |
| Dec 31, 2024 | -0.51% |
| Sep 30, 2024 | 34.83% |
| Jun 30, 2024 | 58.81% |
| Mar 31, 2024 | 14.70% |
| Dec 31, 2023 | 5.80% |
| Sep 30, 2023 | -18.47% |
| Jun 30, 2023 | -10.39% |
| Mar 31, 2023 | 59.31% |
| Dec 31, 2022 | -147.74% |
| Sep 30, 2022 | -276.83% |
| Jun 30, 2022 | 84.46% |
| Jun 30, 2021 | -18.93% |
| Mar 31, 2021 | 65,145.54% |
| Dec 31, 2020 | 98.43% |